Ubs Group Ag Evelo Biosciences, Inc. Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$0.17 - $1.57 $582 - $5,378
3,426 Added 75.07%
7,990 $1,000
Q4 2022

Feb 08, 2023
BUY
$1.44 - $48.2 $2,810 - $94,086
1,952 Added 74.73%
4,564 $7,000
Q3 2022

Nov 10, 2022
BUY
$1.86 - $41.8 $4,858 - $109,181
2,612 New
2,612 $5,000
Q1 2022

May 16, 2022
SELL
$2.66 - $6.63 $33,484 - $83,458
-12,588 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$6.07 - $12.0 $69,501 - $137,400
11,450 Added 1006.15%
12,588 $76,000
Q3 2021

Nov 15, 2021
SELL
$6.79 - $13.9 $9,580 - $19,612
-1,411 Reduced 55.36%
1,138 $8,000
Q2 2021

Aug 13, 2021
SELL
$9.43 - $16.6 $9,081 - $15,985
-963 Reduced 27.42%
2,549 $35,000
Q1 2021

May 12, 2021
SELL
$9.71 - $18.6 $8,428 - $16,144
-868 Reduced 19.82%
3,512 $38,000
Q4 2020

Feb 11, 2021
BUY
$3.91 - $12.28 $12,394 - $38,927
3,170 Added 261.98%
4,380 $53,000
Q3 2020

Nov 12, 2020
SELL
$3.81 - $5.73 $13,342 - $20,066
-3,502 Reduced 74.32%
1,210 $6,000
Q2 2020

Jul 31, 2020
SELL
$3.53 - $6.12 $11,758 - $20,385
-3,331 Reduced 41.41%
4,712 $23,000
Q1 2020

May 01, 2020
SELL
$3.21 - $7.06 $28,976 - $63,730
-9,027 Reduced 52.88%
8,043 $30,000
Q4 2019

Feb 14, 2020
BUY
$3.81 - $7.45 $15,285 - $29,889
4,012 Added 30.72%
17,070 $69,000
Q3 2019

Nov 14, 2019
BUY
$5.45 - $8.8 $51,191 - $82,658
9,393 Added 256.29%
13,058 $80,000
Q2 2019

Aug 14, 2019
BUY
$6.52 - $9.42 $22,676 - $32,762
3,478 Added 1859.89%
3,665 $33,000
Q1 2019

May 14, 2019
SELL
$7.5 - $15.31 $47,850 - $97,677
-6,380 Reduced 97.15%
187 $2,000
Q4 2018

Feb 14, 2019
BUY
$7.29 - $13.01 $32,360 - $57,751
4,439 Added 208.6%
6,567 $85,000
Q3 2018

Nov 14, 2018
BUY
$11.93 - $14.76 $17,895 - $22,140
1,500 Added 238.85%
2,128 $26,000
Q2 2018

Aug 14, 2018
BUY
$11.39 - $16.26 $7,152 - $10,211
628 New
628 $7,000

About Evelo Biosciences, Inc.

EVLO Quotes by TradingView
  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email